143 related articles for article (PubMed ID: 8822945)
81. Characterization of genomic BCR-ABL breakpoints in chronic myeloid leukaemia by PCR.
Zhang JG; Goldman JM; Cross NC
Br J Haematol; 1995 May; 90(1):138-46. PubMed ID: 7786776
[TBL] [Abstract][Full Text] [Related]
82. Ph1+bcr- acute leukemias: implication of Alu sequences in a chromosomal translocation occurring in the new cluster region within the BCR gene.
Chen SJ; Chen Z; d'Auriol L; Le Coniat M; Grausz D; Berger R
Oncogene; 1989 Feb; 4(2):195-202. PubMed ID: 2648256
[TBL] [Abstract][Full Text] [Related]
83. Translocation of BCR to chromosome 9 in a Philadelphia-negative chronic myeloid leukemia.
Brunel V; Sainty D; Costello R; Mozziconacci MJ; Simonetti J; Arnoulet C; Coignet L; Bouabdallah R; Gastaut JA; Gabert J
Cancer Genet Cytogenet; 1995 Nov; 85(1):82-4. PubMed ID: 8536245
[TBL] [Abstract][Full Text] [Related]
84. BCR breakpoint location and prognosis in CML.
Leibowitz D
Blood; 1989 May; 73(6):1745-6. PubMed ID: 2653462
[No Abstract] [Full Text] [Related]
85. bcr genes and transcripts.
Lifshitz B; Fainstein E; Marcelle C; Shtivelman E; Amson R; Gale RP; Canaani E
Oncogene; 1988 Feb; 2(2):113-7. PubMed ID: 3285291
[TBL] [Abstract][Full Text] [Related]
86. CGG-repeat polymorphism of the BCR gene rules out predisposing alleles leading to the Philadelphia chromosome.
Riggins GJ; Sherman SL; Phillips CN; Stock W; Westbrook CA; Warren ST
Genes Chromosomes Cancer; 1994 Feb; 9(2):141-4. PubMed ID: 7513545
[TBL] [Abstract][Full Text] [Related]
87. Possible prediction of myeloid and lymphoid crises in chronic myelocytic leukemia at onset by determining the methylation status of the major breakpoint cluster region.
Ge XQ; Tanaka K; Mansyur A; Tazawa H; Iwato K; Kyo T; Dohy H; Kamada N
Cancer Genet Cytogenet; 2001 Apr; 126(2):102-10. PubMed ID: 11376802
[TBL] [Abstract][Full Text] [Related]
88. Clinical impact of breakpoint position within M-bcr in chronic myeloid leukemia.
Fioretos T; Nilsson PG; Aman P; Heim S; Kristoffersson U; Malm C; Simonsson B; Turesson I; Mitelman F
Leukemia; 1993 Aug; 7(8):1225-31. PubMed ID: 8350622
[TBL] [Abstract][Full Text] [Related]
89. Characterization of the translocation breakpoint in a patient with Philadelphia positive, bcr negative acute lymphoblastic leukaemia.
van der Feltz MJ; Shivji MK; Grosveld G; Wiedemann LM
Oncogene; 1988 Aug; 3(2):215-9. PubMed ID: 3166123
[TBL] [Abstract][Full Text] [Related]
90. Rearrangement of the breakpoint cluster region and expression of P210 BCR-ABL in a "masked" Philadelphia chromosome-positive acute myeloid leukemia.
Price CM; Rassool F; Shivji MK; Gow J; Tew CJ; Haworth C; Goldman JM; Wiedemann LM
Blood; 1988 Nov; 72(5):1829-32. PubMed ID: 3179449
[TBL] [Abstract][Full Text] [Related]
91. Ph-negative chronic myeloid leukemia: molecular analysis of ABL insertion into M-BCR on chromosome 22.
Morris CM; Heisterkamp N; Kennedy MA; Fitzgerald PH; Groffen J
Blood; 1990 Nov; 76(9):1812-8. PubMed ID: 2171702
[TBL] [Abstract][Full Text] [Related]
92. Leukemia cell lines: in vitro models for the study of Philadelphia chromosome-positive leukemia.
Drexler HG; MacLeod RA; Uphoff CC
Leuk Res; 1999 Mar; 23(3):207-15. PubMed ID: 10071072
[TBL] [Abstract][Full Text] [Related]
93. Molecular biology of the Philadelphia positive leukaemias.
Morgan GJ; Wiedemann LM
Recenti Prog Med; 1989 Oct; 80(10):508-19. PubMed ID: 2690217
[TBL] [Abstract][Full Text] [Related]
94. Clinical relevance of the breakpoint sites within the M-BCR in 50 patients from Argentina with chronic myeloid leukemia.
Giere IA; Larripa IB
Leuk Lymphoma; 1996 Aug; 22(5-6):519-22. PubMed ID: 8882967
[TBL] [Abstract][Full Text] [Related]
95. Nucleotide sequence of both reciprocal translocation junction regions in a patient with Ph positive acute lymphoblastic leukaemia, with a breakpoint within the first intron of the BCR gene.
van der Feltz MJ; Shivji MK; Allen PB; Heisterkamp N; Groffen J; Wiedemann LM
Nucleic Acids Res; 1989 Jan; 17(1):1-10. PubMed ID: 2911461
[TBL] [Abstract][Full Text] [Related]
96. A novel BCR-ABL fusion gene (e6a2) in a patient with Philadelphia chromosome-negative chronic myelogenous leukemia.
Hochhaus A; Reiter A; Skladny H; Melo JV; Sick C; Berger U; Guo JQ; Arlinghaus RB; Hehlmann R; Goldman JM; Cross NC
Blood; 1996 Sep; 88(6):2236-40. PubMed ID: 8822944
[TBL] [Abstract][Full Text] [Related]
97. Absence in Ph-negative, M-BCR rearrangement-positive chronic myelogenous leukemia of linkage between 5' ABL and 3' M-BCR sequences in Philadelphia translocation.
Nishigaki H; Misawa S; Inazawa J; Abe T
Leukemia; 1992 May; 6(5):385-92. PubMed ID: 1593904
[TBL] [Abstract][Full Text] [Related]
98. Interstitial insertion of varying amounts of ABL-containing genetic material into chromosome 22 in Ph-negative CML.
Rassool F; Martiat P; Taj A; Klisak I; Goldman J
Leukemia; 1990 Apr; 4(4):273-7. PubMed ID: 2164119
[TBL] [Abstract][Full Text] [Related]
99. Deletions adjacent to BCR and ABL1 breakpoints occur in a substantial minority of chronic myeloid leukemia patients with masked Philadelphia rearrangements.
De Melo VA; Milojkovic D; Marin D; Apperley JF; Nacheva EP; Reid AG
Cancer Genet Cytogenet; 2008 Apr; 182(2):111-5. PubMed ID: 18406872
[TBL] [Abstract][Full Text] [Related]
100. BCR-ABL gene variants.
Melo JV
Baillieres Clin Haematol; 1997 Jun; 10(2):203-22. PubMed ID: 9376660
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
